Trademark Overview
On Friday, March 13, 2026, a trademark application was filed for QUTYLILEY with the United States Patent and Trademark Office. The USPTO has given the QUTYLILEY trademark a serial number of 99702159. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Monday, June 22, 2026. The QUTYLILEY trademark is filed in the Pharmaceutical Products category with the following description:
Medicinal plant and herb extracts sold as an integral component of medicated cosmetics; Placebo pills for medical use; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting metabolism; Pain relief medication; Medicated supplements for foodstuffs for babies; Domestic biopesticides; Antivirals; Antipyretic analgesics; Anti-inflammatories; Antidotes; Allergy relief medication; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use
